中国基层医药
中國基層醫藥
중국기층의약
CHINESE JOURNAL OF PRIMARY MEDICINE AND PHARMACY
2014年
13期
1984-1986
,共3页
妊娠,高危%高血压,妊娠性%药物疗法,联合%干预性研究
妊娠,高危%高血壓,妊娠性%藥物療法,聯閤%榦預性研究
임신,고위%고혈압,임신성%약물요법,연합%간예성연구
Pregnancy,high-pisk%Hypertension,pregnancy-induced%Drug therapy,combination%Intervention studies
目的 观察抗凝剂联合钙剂、维生素E对妊娠期高血压疾病高危患者早期干预的临床疗效.方法 选取113例妊娠期高血压疾病高危患者作为观察对象,按孕前检测血栓前状态情况分为观察一组38例、观察二组43例、对照组32例,观察一组于孕前开始干预,观察二组孕中干预,对照组孕中出现异常时干预.比较三组妊娠期高血压疾病发生率、产科并发症发生率、宫内窘迫及新生儿窒息的发生率.结果 观察一组妊娠期高血压疾病发生率、产科并发症发生率、宫内窘迫及新生儿窒息发生率分别为5.26％、7.89％、5.26％、5.26％,观察二组分别为20.93％、9.3％、18.6％、20.93％,对照组分别为43.75％、28.13％、43.75％、48.88％,观察一组与对照组差异均有统计学意义(x2=14.59、5.01、14.59、16.36,均P＜0.05),观察二组与对照组差异均有统计学意义(x2 =4.49、4.54、5.60、5.68,均P＜0.05),观察一组与观察二组妊娠期高血压疾病发生率、新生儿窒息发生率差异均有统计学意义(x2=4.22、4.22,均P＜0.05).结论 抗凝剂联合钙剂、维生素E对妊娠期高血压疾病高危患者进行干预,可有效的纠正不良妊娠结局,并改善围生儿预后,且早期进行干预效果更好.
目的 觀察抗凝劑聯閤鈣劑、維生素E對妊娠期高血壓疾病高危患者早期榦預的臨床療效.方法 選取113例妊娠期高血壓疾病高危患者作為觀察對象,按孕前檢測血栓前狀態情況分為觀察一組38例、觀察二組43例、對照組32例,觀察一組于孕前開始榦預,觀察二組孕中榦預,對照組孕中齣現異常時榦預.比較三組妊娠期高血壓疾病髮生率、產科併髮癥髮生率、宮內窘迫及新生兒窒息的髮生率.結果 觀察一組妊娠期高血壓疾病髮生率、產科併髮癥髮生率、宮內窘迫及新生兒窒息髮生率分彆為5.26％、7.89％、5.26％、5.26％,觀察二組分彆為20.93％、9.3％、18.6％、20.93％,對照組分彆為43.75％、28.13％、43.75％、48.88％,觀察一組與對照組差異均有統計學意義(x2=14.59、5.01、14.59、16.36,均P＜0.05),觀察二組與對照組差異均有統計學意義(x2 =4.49、4.54、5.60、5.68,均P＜0.05),觀察一組與觀察二組妊娠期高血壓疾病髮生率、新生兒窒息髮生率差異均有統計學意義(x2=4.22、4.22,均P＜0.05).結論 抗凝劑聯閤鈣劑、維生素E對妊娠期高血壓疾病高危患者進行榦預,可有效的糾正不良妊娠結跼,併改善圍生兒預後,且早期進行榦預效果更好.
목적 관찰항응제연합개제、유생소E대임신기고혈압질병고위환자조기간예적림상료효.방법 선취113례임신기고혈압질병고위환자작위관찰대상,안잉전검측혈전전상태정황분위관찰일조38례、관찰이조43례、대조조32례,관찰일조우잉전개시간예,관찰이조잉중간예,대조조잉중출현이상시간예.비교삼조임신기고혈압질병발생솔、산과병발증발생솔、궁내군박급신생인질식적발생솔.결과 관찰일조임신기고혈압질병발생솔、산과병발증발생솔、궁내군박급신생인질식발생솔분별위5.26％、7.89％、5.26％、5.26％,관찰이조분별위20.93％、9.3％、18.6％、20.93％,대조조분별위43.75％、28.13％、43.75％、48.88％,관찰일조여대조조차이균유통계학의의(x2=14.59、5.01、14.59、16.36,균P＜0.05),관찰이조여대조조차이균유통계학의의(x2 =4.49、4.54、5.60、5.68,균P＜0.05),관찰일조여관찰이조임신기고혈압질병발생솔、신생인질식발생솔차이균유통계학의의(x2=4.22、4.22,균P＜0.05).결론 항응제연합개제、유생소E대임신기고혈압질병고위환자진행간예,가유효적규정불량임신결국,병개선위생인예후,차조기진행간예효과경호.
Objective To observe the clinical curative effect of anticoagulants combined with calcium,vitamin E in pregnancy induced hypertension patients at high risk for early intervention.Methods 113 patients with hypertensive disorder complicating pregnancy were selected as the observation subjects,according to the detection of prethrombotic state before pregnancy,they were divided into observation group one 38 cases,group two 43 cases,control group 32 cases.The observation group one was given intervention preconception,the group two was given intervention during pregnancy,the control group was given intervention when abnormal.The incidence rates of obstetric complication,intrauterine distress and neonatal asphyxia were compared among the three groups.Results The incidence rates of hypertension,obstetric complications,intrauterine distress and neonatal asphyxia in the group one were 5.26％,7.89％,5.26％,5.26％,those in the group two were 20.93 ％,9.3 ％,18.6％,20.93 ％,those in the control group were 43.75％,28.13％,43.75％,48.88％,the differences between the observation group one and control group showed significant differences(x2 =14.59,5.01,14.59,16.36,all P ＜ 0.05),the differences between the group two and the control group were statistically significant (x2 =4.49,4.54,5.60,5.68,all P ＜ 0.05),the incidence rates of hypertension,neonatal asphyxia between the observation group one and group two had statistically significant differences (x2 =4.22,4.22,all P ＜ 0.05).Conclusion Anticoagulants combined with calcium,vitamin E in the treatment of patients with hypertensive disorder complicating pregnancy,can effectively correct the adverse pregnancy outcomes,and improve the prognosis of perinatal infants,and early intervention is better.
